FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3020975059> ?p ?o ?g. }

• W3020975059 abstract "You have accessJournal of UrologyProstate Cancer: Localized: Surgical Therapy I (MP19)1 Apr 2020MP19-07 LONGITUDINAL ANALYSIS OF TRIFECTA OUTCOME IN ROBOT-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY Shogo Inoue*, Keisuke Hieda, Tetsutaro Hayashi, Jun Teishima, and Akio Matsubara Shogo Inoue*Shogo Inoue* More articles by this author , Keisuke HiedaKeisuke Hieda More articles by this author , Tetsutaro HayashiTetsutaro Hayashi More articles by this author , Jun TeishimaJun Teishima More articles by this author , and Akio MatsubaraAkio Matsubara More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000000852.07AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Our objective was to analyze the trifecta outcome (continence, potency, and cancer control) longitudinally in robot-assisted laparoscopic radical prostatectomy (RARP). METHODS: We prospectively obtained one-year longitudinal Expanded Prostate Cancer Index Composite (EPIC) data (preoperative and at 3, 6, 9, and 12 months after RARP) from 458 patients who underwent RARP performed by a single surgeon. Of these, we excluded 167 patients with incontinence or erectile dysfunction patients at preoperative. Continence was defined as the use of ‘zero or one pads’. Potency was defined as the ability to achieve and maintain satisfactory erections firm enough for sexual activity or sexual intercourse. The biochemical recurrence rate was defined as two consecutive PSA levels of > 0.2 ng/mL after RARP. RESULTS: Patient characteristics are listed in Table 1. Trifecta was achieved in 4.6, 5.6, 8.1, and 9.6% of patients at 3, 6, 9, and 12 months, respectively. Trifecta rates in the nerve-sparing group were 12.9, 12.7, 18.9, and 22.5%, respectively (Fig. 1). Cancer control rates maintained a high level longitudinally and these rates were 94.4, 93.9, 93.9, and 90.0%, respectively. Continence rate was improved to be 55.2, 75.5, 81.6, and 85.0%. On the other hand, the potency rate was extremely low, at 7.5, 7.8, 9.8, and 10.9%(Fig. 2). Even in nerve-sparing group, the cancer control rate was very high and continence was recovered, which suggests similar tendencies among cancer control and continence. Potency rate remained low at 19.4, 18.6, 21.9, and 25.0%, respectively. CONCLUSIONS: Trifecta outcomes more accurately reflect patient expectations following RARP. In our longitudinal analysis, potency rate was found to be associated with the achievement of trifecta. Source of Funding: None © 2020 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 203Issue Supplement 4April 2020Page: e300-e300 Advertisement Copyright & Permissions© 2020 by American Urological Association Education and Research, Inc.MetricsAuthor Information Shogo Inoue* More articles by this author Keisuke Hieda More articles by this author Tetsutaro Hayashi More articles by this author Jun Teishima More articles by this author Akio Matsubara More articles by this author Expand All Advertisement PDF downloadLoading ..." @default.
• W3020975059 created "2020-05-13" @default.
• W3020975059 creator A5016698641 @default.
• W3020975059 creator A5038516654 @default.
• W3020975059 creator A5046195007 @default.
• W3020975059 creator A5074175540 @default.
• W3020975059 creator A5085521043 @default.
• W3020975059 date "2020-04-01" @default.
• W3020975059 modified "2023-09-27" @default.
• W3020975059 title "MP19-07 LONGITUDINAL ANALYSIS OF TRIFECTA OUTCOME IN ROBOT-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY" @default.
• W3020975059 doi "https://doi.org/10.1097/ju.0000000000000852.07" @default.
• W3020975059 hasPublicationYear "2020" @default.
• W3020975059 type Work @default.
• W3020975059 sameAs 3020975059 @default.
• W3020975059 citedByCount "0" @default.
• W3020975059 crossrefType "journal-article" @default.
• W3020975059 hasAuthorship W3020975059A5016698641 @default.
• W3020975059 hasAuthorship W3020975059A5038516654 @default.
• W3020975059 hasAuthorship W3020975059A5046195007 @default.
• W3020975059 hasAuthorship W3020975059A5074175540 @default.
• W3020975059 hasAuthorship W3020975059A5085521043 @default.
• W3020975059 hasBestOaLocation W30209750591 @default.
• W3020975059 hasConcept C115519274 @default.
• W3020975059 hasConcept C121608353 @default.
• W3020975059 hasConcept C124952713 @default.
• W3020975059 hasConcept C126322002 @default.
• W3020975059 hasConcept C126894567 @default.
• W3020975059 hasConcept C141071460 @default.
• W3020975059 hasConcept C142362112 @default.
• W3020975059 hasConcept C185592680 @default.
• W3020975059 hasConcept C202751555 @default.
• W3020975059 hasConcept C2777008409 @default.
• W3020975059 hasConcept C2779466945 @default.
• W3020975059 hasConcept C2779819210 @default.
• W3020975059 hasConcept C2779929075 @default.
• W3020975059 hasConcept C2780192828 @default.
• W3020975059 hasConcept C2993211783 @default.
• W3020975059 hasConcept C55493867 @default.
• W3020975059 hasConcept C57992300 @default.
• W3020975059 hasConcept C61434518 @default.
• W3020975059 hasConcept C71924100 @default.
• W3020975059 hasConceptScore W3020975059C115519274 @default.
• W3020975059 hasConceptScore W3020975059C121608353 @default.
• W3020975059 hasConceptScore W3020975059C124952713 @default.
• W3020975059 hasConceptScore W3020975059C126322002 @default.
• W3020975059 hasConceptScore W3020975059C126894567 @default.
• W3020975059 hasConceptScore W3020975059C141071460 @default.
• W3020975059 hasConceptScore W3020975059C142362112 @default.
• W3020975059 hasConceptScore W3020975059C185592680 @default.
• W3020975059 hasConceptScore W3020975059C202751555 @default.
• W3020975059 hasConceptScore W3020975059C2777008409 @default.
• W3020975059 hasConceptScore W3020975059C2779466945 @default.
• W3020975059 hasConceptScore W3020975059C2779819210 @default.
• W3020975059 hasConceptScore W3020975059C2779929075 @default.
• W3020975059 hasConceptScore W3020975059C2780192828 @default.
• W3020975059 hasConceptScore W3020975059C2993211783 @default.
• W3020975059 hasConceptScore W3020975059C55493867 @default.
• W3020975059 hasConceptScore W3020975059C57992300 @default.
• W3020975059 hasConceptScore W3020975059C61434518 @default.
• W3020975059 hasConceptScore W3020975059C71924100 @default.
• W3020975059 hasIssue "Supplement 4" @default.
• W3020975059 hasLocation W30209750591 @default.
• W3020975059 hasOpenAccess W3020975059 @default.
• W3020975059 hasPrimaryLocation W30209750591 @default.
• W3020975059 hasRelatedWork W2128283707 @default.
• W3020975059 hasRelatedWork W2154801101 @default.
• W3020975059 hasRelatedWork W2369540220 @default.
• W3020975059 hasRelatedWork W2912622022 @default.
• W3020975059 hasRelatedWork W2949118754 @default.
• W3020975059 hasRelatedWork W3031598457 @default.
• W3020975059 hasRelatedWork W3199205716 @default.
• W3020975059 hasRelatedWork W3203314486 @default.
• W3020975059 hasRelatedWork W4200041489 @default.
• W3020975059 hasRelatedWork W4211244656 @default.
• W3020975059 hasVolume "203" @default.
• W3020975059 isParatext "false" @default.
• W3020975059 isRetracted "false" @default.
• W3020975059 magId "3020975059" @default.
• W3020975059 workType "article" @default.